- Biomerica ( NASDAQ: BMRA ) has priced its public offering of ~3.3M shares of common stock at $2.40 per share, for gross proceeds of ~$8M.
- Craig-Hallum Capital Group is acting as sole managing underwriter for the offering.
- Net proceeds will be used for general corporate purposes, including, conducting clinical studies, expanding sales and marketing activities for existing and new products, R&D, acquisitions, capital expenditures, and for other general working capital needs.
- Closing date is March 7, 2023.
- Shares down 2.5% premarket at $2.71.
- Previously (March 2): Biomerica stock slumps ~18% after hours on proposed public stock offering
For further details see:
Biomerica raises $8M capital via stock offering